164 related articles for article (PubMed ID: 36731809)
1. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
2. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
[TBL] [Abstract][Full Text] [Related]
3. Midkine mediates dysfunction of liver sinusoidal endothelial cells through integrin α4 and α6.
Wu L; Chen H; Fu C; Xing M; Fang H; Yang F; Yang Q; Zhang Y; Li W; Chen Z
Vascul Pharmacol; 2022 Dec; 147():107113. PubMed ID: 36184060
[TBL] [Abstract][Full Text] [Related]
4. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Wu L; Yang FR; Xing ML; Lu SF; Chen HL; Yang QW; Zhang YT; Lu Y; Huang Y
Phytomedicine; 2022 Jun; 100():154055. PubMed ID: 35344716
[TBL] [Abstract][Full Text] [Related]
5. Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites.
He X; Liang J; Li X; Wang Y; Zhang X; Chen D; Wu L; Wang S
J Ethnopharmacol; 2024 Mar; 321():117402. PubMed ID: 37967779
[TBL] [Abstract][Full Text] [Related]
6. Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway.
Gong Z; Lin J; Zheng J; Wei L; Liu L; Peng Y; Liang W; Hu G
J Cell Biochem; 2020 Feb; 121(2):1431-1440. PubMed ID: 31502329
[TBL] [Abstract][Full Text] [Related]
7. A meritorious integrated medical regimen for hepatic fibrosis and its complications
Ye Z; Huang Q; She Y; Hu Y; Wu M; Qin K; Li L; Zhang C; Zuo X; Wei A; Mao D; Ye Q
Front Med (Lausanne); 2022; 9():920062. PubMed ID: 36314011
[TBL] [Abstract][Full Text] [Related]
8. Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg/Th1 balance.
Chen TT; DU SL; Wang SJ; Wu L; Yin L
Chin J Nat Med; 2022 Feb; 20(2):102-110. PubMed ID: 35279237
[TBL] [Abstract][Full Text] [Related]
9. [Effect and mechanism of Dahuang Zhechong Pills in improving liver aging in rats by regulating ROS-mediated PI3K/Akt/FoxO4 signaling pathway].
Fu Y; Wu W; Wan YG; Yang HM; Tu Y; Liu SY; Fang QJ; Liu YL; Wang MZ; Huang H
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3014-3021. PubMed ID: 37381959
[TBL] [Abstract][Full Text] [Related]
10. Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis.
Gong Z; Deng C; Xiao H; Peng Y; Hu G; Xiang T; Tao L; Zheng J
J Tradit Chin Med; 2018 Apr; 38(2):190-196. PubMed ID: 32186058
[TBL] [Abstract][Full Text] [Related]
11. Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization.
Chen H; Yang F; Fu C; Zhang Z; Xu K; Lu S; Chen Z; Wu L; Li W
Biomed Chromatogr; 2022 May; 36(5):e5305. PubMed ID: 34967034
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the pharmacodynamic substances in dahuang zhechong pill that inhibit energy metabolism.
Ni ZH; Wu L; Cao KX; Zhang XQ; Wang DY; Zeng YW; Liang LL; Qiu XD; Guo RS; Cheng HB; Chen ZP
J Ethnopharmacol; 2020 Apr; 251():112332. PubMed ID: 31669443
[TBL] [Abstract][Full Text] [Related]
13. Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway.
Zhao ZM; Liu HL; Sun X; Guo T; Shen L; Tao YY; Liu CH
Exp Biol Med (Maywood); 2017 May; 242(9):974-985. PubMed ID: 28440736
[TBL] [Abstract][Full Text] [Related]
14. [Effect and mechanism of Dahuang Zhechong Pills against testicular aging in rats by inhibiting necroptosis signaling pathway].
Li H; Tu Y; Wan YG; Mu GL; Wu W; Chen JX; Wang MZ; Wang J; Fu Y; Cai YF; Wang Y; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4119-4127. PubMed ID: 36046902
[TBL] [Abstract][Full Text] [Related]
15. [Effect of dahuang zhechong pill on transforming growth factor-beta 1 in hepatic stellate cells in rats].
Li L; Xu M; Liu ZL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):763-6. PubMed ID: 14626192
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Th1/2 cells influences hepatic capillarization by adjusting sinusoidal endothelial fenestrae through Rho-ROCK-myosin pathway.
Zhong Y; Xu M; Hu J; Huang X; Lin N; Deng M
Aging (Albany NY); 2021 Feb; 13(4):5069-5086. PubMed ID: 33535174
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the VEGF/AKT/eNOS signaling pathway to regulate liver angiogenesis to explore the anti-hepatic fibrosis mechanism of curcumol.
Zheng Y; Wang J; Zhao T; Wang L; Wang J
J Ethnopharmacol; 2021 Nov; 280():114480. PubMed ID: 34358654
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma.
Li H
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):217-233. PubMed ID: 33131349
[No Abstract] [Full Text] [Related]
19. Simultaneous determination of nineteen compounds of Dahuang zhechong pill in rat plasma by UHPLC-MS/MS and its application in a pharmacokinetic study.
Wu L; Du S; Yang F; Ni Z; Chen Z; Liu X; Wang Y; Zhou Q; Li W; Qin K
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1151():122200. PubMed ID: 32526664
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of inhibiting proliferation of vascular smooth muscle cells by serum of rats treated with Dahuang Zhechong pill.
Zhang YH; Liu JT; Wen BY; Liu N
J Ethnopharmacol; 2009 Jul; 124(1):125-9. PubMed ID: 19527826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
